HP
HealthInvest Partners Portfolio holdings
AUM $234M
1-Year Return
10.88%
This Quarter Return
+0.9%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$218M
AUM Growth
+$4.51M
(+2.1%)
Cap. Flow
-$3.82M
Cap. Flow
% of AUM
-1.75%
Top 10 Holdings %
Top 10 Hldgs %
66.25%
Holding
22
New
4
Increased
3
Reduced
9
Closed
4
Top Buys
| 1 |
Cencora
COR
|
+$12.7M |
| 2 |
Cardinal Health
CAH
|
+$12.5M |
| 3 |
CXRX
Concordia International Corp. Common Stock
CXRX
|
+$11.7M |
| 4 |
INSY
Insys Therapeutics, Inc.
INSY
|
+$10.2M |
| 5 |
GNC
GNC Holdings, Inc.
GNC
|
+$2.31M |
Top Sells
| 1 |
FEIC
FEI COMPANY
FEIC
|
+$12.9M |
| 2 |
Bausch Health
BHC
|
+$9.73M |
| 3 |
LPNT
LifePoint Health, Inc.
LPNT
|
+$5.79M |
| 4 |
Supernus Pharmaceuticals
SUPN
|
+$5.01M |
| 5 |
Anika Therapeutics
ANIK
|
+$4.17M |
Sector Composition
| 1 | Healthcare | 73.26% |
| 2 | Industrials | 7.6% |
| 3 | Financials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Anika Therapeutics
ANIK
$125M
| $22.1M | 10.15% |
412,588
-77,743
| -16% | -$4.17M |
|
|
GNC
2
DELISTED
GNC Holdings, Inc.
GNC
| $16.6M | 7.6% |
681,955
+95,000
| +16% | +$2.31M |
|
|
AMAG
3
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $16.1M | 7.37% |
671,585
-69,000
| -9% | -$1.65M |
|
|
4
Supernus Pharmaceuticals
SUPN
$2.47B
| $13.4M | 6.14% |
657,533
-246,000
| -27% | -$5.01M |
|
|
GTS
5
DELISTED
Triple-S Management Corporation
GTS
| $13M | 5.97% |
560,110
+30,535
| +6% | +$710K |
|
6
Merck
MRK
$202B
| $12.9M | 5.92% |
234,857
-28,610
| -11% | -$1.57M |
|
|
7
Cencora
COR
$56.5B
| $12.7M | 5.82% |
+160,000
| New | +$12.7M |
|
|
FEIC
8
DELISTED
FEI COMPANY
FEIC
| $12.7M | 5.81% |
118,609
-121,000
| -50% | -$12.9M |
|
|
TARO
9
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $12.6M | 5.76% |
86,205
-7,800
| -8% | -$1.14M |
|
|
10
Cardinal Health
CAH
$35.9B
| $12.5M | 5.72% |
+160,000
| New | +$12.5M |
|
11
Charles River Laboratories
CRL
$7.49B
| $12.3M | 5.66% |
149,612
-28,695
| -16% | -$2.37M |
|
12
Elevance Health
ELV
$69.1B
| $12.3M | 5.66% |
93,900
| – | – |
|
|
LPNT
13
DELISTED
LifePoint Health, Inc.
LPNT
| $12.1M | 5.57% |
185,851
-88,579
| -32% | -$5.79M |
|
|
CXRX
14
DELISTED
Concordia International Corp. Common Stock
CXRX
| $11.7M | 5.36% |
+543,000
| New | +$11.7M |
|
|
SYNH
15
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $10.9M | 5% |
286,270
-38,000
| -12% | -$1.45M |
|
|
INSY
16
DELISTED
Insys Therapeutics, Inc.
INSY
| $10.2M | 4.68% |
+788,175
| New | +$10.2M |
|
17
OraSure Technologies
OSUR
$236M
| $2.81M | 1.29% |
475,771
+70,000
| +17% | +$414K |
|
18
ImmuCell
ICCC
$53.8M
| $1.16M | 0.53% |
168,323
| – | – |
|
19
Assertio
ASRT
$77.3M
| – | – |
-50,000
| Closed | -$2.79M |
|
|
20
Bausch Health
BHC
$2.66B
| – | – |
-370,000
| Closed | -$9.73M |
|
|
SCLN
21
DELISTED
Sciclone Pharmaceuticals Inc
SCLN
| – | – |
-236,288
| Closed | -$2.6M |
|
|
SSRG
22
DELISTED
SYMMETRY SURGICAL INC COMMON STK
SSRG
| – | – |
-316,427
| Closed | -$3.12M |
|